QUBES will have scheduled maintenance work on Tuesday, December 17, 2024, beginning sometime between 5 pm PST and 11:59 pm PST, with downtime lasting approximately 30 minutes. All running tool sessions will expire during the maintenance window. Please plan accordingly and we do apologize for any inconvenience. close

Text Search:
Applied Filters
    Evaluating the potential for immune escape: how likely is an antibody to protect against a specific SARS-CoV-2 variant?
    Commercial antibodies to the SARS-CoV-2 spike protein have been successfully used to treat people with COVID-19. Unfortunately, as the SARS-CoV-2 virus evolves, new variants have appeared that can...
    195

    views

    260

    downloads

    0

    comments

    0

    adaptations

    Drugging SARS-CoV-2
    This case study leads students through the process of proposing a drug for a novel protein. The Mpro protease of SARS-CoV-2 is explored in detail within the PDB. Aligns with first semester...
    1383

    views

    397

    downloads

    0

    comments

    0

    adaptations

    Evaluating the potential for immune escape: how likely is an antibody to protect against a specific SARS-CoV-2 variant?
    Commercial antibodies to the SARS-CoV-2 spike protein have been successfully used to treat people with COVID-19. Unfortunately, as the SARS-CoV-2 virus evolves, new variants have appeared that can...
    1795

    views

    1491

    downloads

    0

    comments

    1

    adaptations